MD An­der­son, Flag­ship start­up part­ner to de­sign and test can­cer drugs made with gen­er­a­tive AI

Gen­er­ate Bio­med­i­cines, a start­up found­ed by the life sci­ence in­vest­ment com­pa­ny Flag­ship Pi­o­neer­ing, has part­nered with the Uni­ver­si­ty of Texas MD An­der­son Can­cer Cen­ter to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER